Mylan Presses On With US Tecfidera Launch ‘At Risk’

Follows First FDA Approval For Rival To MS Blockbuster

 
• By Dean Rudge
Risk
Mylan has launched the first generic Tecfidera product in the US despite ongoing litigation • Source: Shutterstock

More from New Products

More from Scrip